Standing out from the crowd: key rules to medical technology market success
This article was originally published in Clinica
For medical technology executives seeking to grow their business, strategy guidance that is industry-specific and research-based is hard to come by. After 20 years working in the sector, a PhD and 10 years of market strategy research at two of Europe's leading business schools, Dr Brian D Smith explores what it is that gives successful companies the edge over others in the medtech market
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.